Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sequenom, Inc. (SQNM) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (99)	5/17/2002 5:39:15 AM
From: nigel bates	Read Replies (2) \| Respond to of 364

newscientist.com ...now it turns out that Genetic Technologies of Melbourne owns a slew of patents, registered in the name of GeneType of Switzerland, covering the very concept of much SNP analysis. "All [the companies] that are using non-coding SNPs are infringing our patents, knowingly or unknowingly," says the chairman of Genetic Technologies, Mervyn Jacobson... ...Sequenom of San Diego, for instance, which sells high-throughput SNP analysis equipment, paid $500,000 for a non-exclusive licence. And the deals are unlikely to get any cheaper. As part of the agreement with Sequenom, Genetic Technologies guaranteed that licences issued to other companies would cost more...